Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

NCT00906516 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Tumors

Interventions

DRUG: Neuradiab in combination with Bevacizumab (Avastin)

Sponsor

Bradmer Pharmaceuticals Inc.